Dosing regimens before and following long-term treatment with recombinant factor VIII Fc fusion protein (rFVIIIFc) in adults and adolescents with severe hemophilia A

被引：0
|
作者：
Konkle, Barbara A. [1 ]
Pasi, K. John [2 ]
Perry, David J. [3 ]
Mahlangu, Johnny [4 ]
Rangarajan, Savita [5 ]
Hanabusa, Hideji [6 ]
Pabinger, Ingrid [7 ]
Lethagen, Stefan [8 ,9 ]
Cristiano, Lynda M. [10 ]
Yuan, Huixing [10 ]
Pierce, Glenn F. [10 ]
Allen, Geoffrey [10 ]
机构：
[1] Bloodworks Northwest, Seattle, WA USA
[2] Barts & London Comprehens Care Ctr, London, England
[3] Addenbrookes Hosp, Cambridge, England
[4] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa
[5] Hampshire Hosp NHS Trust, Basingstoke, Hants, England
[6] Ogikubo Hosp, Tokyo, Japan
[7] Med Univ Wien, Vienna, Austria
[8] Sobi, Stockholm, Sweden
[9] Univ Copenhagen, Copenhagen, Denmark
[10] Biogen, Cambridge, MA USA
来源：
HAEMOPHILIA | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [31] Recombinant coagulation factor VIII Fc-von Willebrand factor fusion protein Treatment of hemophilia A
    Villarreal-Martinez, Laura
    Zamora-Martinez, Paola Lizeth
    DRUGS OF THE FUTURE, 2022, 47 (10) : 711 - 714
  • [32] Interim Analysis Of The ASPIRE Study Evaluating Long-term Safety And Efficacy Of Recombinant Factor VIII FC (RFVIIIFC) In Children With Severe Haemophilia A
    Nolan, B.
    Young, G.
    Mahlangu, J.
    Liesner, R.
    Pasi, J.
    Cristiano, L. M.
    Li, X.
    Pierce, G. F.
    Allen, G.
    HAEMOPHILIA, 2015, 21 : 58 - 59
  • [33] Pharmacokinetics and safety of recombinant factor VIII Fc fusion protein (rFVIIIFc) in a phase 1/2A trial in previously treated patients (PTPS) with severe hemophilia A
    Powell, J.
    Josephson, N. C.
    Quon, D.
    Ragni, M., V
    Cheng, G.
    McKinney, B.
    Jiang, H.
    Li, L.
    Dumont, J.
    Goyal, J.
    Sommer, J.
    Luk, A.
    Pierce, G. F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 283 - 283
  • [34] Long-Term Safety and Efficacy of rFVIIIFc in Adults and Adolescents with Severe Hemophilia A: A Longitudinal Analysis of A- LONG and ASPIRE
    Pasi, K. John
    Perry, David J.
    Mahlangu, Johnny
    Konkle, Barbara A.
    Rangarajan, Savita
    Brown, Simon
    Hanabusa, Hideji
    Jackson, Shannon
    Pabinger, Ingrid
    Cristiano, Lynda M.
    Dong, Yingwen
    Tsao, Elisa
    Pierce, Glenn F.
    Allen, Geoffrey
    BLOOD, 2015, 126 (23)
  • [35] Long-term outcomes of prophylaxis with a recombinant factor VIII Fc or recombinant factor IX Fc in patients with hemophilia previously treated on demand
    Alvarez-Roman, Maria-Teresa
    Shapiro, Amy D.
    Ragni, Margaret V.
    Palmborg, Helena
    Bystricka, Linda
    Szamosi, Johan
    Casiano, Sandra
    Chambost, Herve
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (06)
  • [36] Dosing Long-Lasting Recombinant Factor VIII Fc Fusion Protein: Experience In The A-LONG Study
    Shapiro, Amy
    Ragni, Margaret V.
    Kulkarni, Roshni
    Kulke, Sarah
    Potts, James
    Neelakantan, Srividya
    Nestorov, Ivan
    Dumont, Jennifer A.
    Jiang, Haiyan
    Brennan, Aoife
    Pierce, Glenn F.
    BLOOD, 2013, 122 (21)
  • [37] Subject-Reported Changes in Physical Activity During The A-LONG Study of Recombinant Factor VIII FC Fusion Protein (RFVIIIFC) for Severe Haemophilia A
    Klamroth, R.
    Quon, D. V.
    Kulkarni, R.
    Shapiro, A. D.
    Baker, R. I.
    Castaman, G.
    Innes, A.
    Allen, G.
    HAEMOPHILIA, 2015, 21 : 34 - 34
  • [38] Safety, Efficacy, and Pharmacokinetics of Recombinant Factor VIII FC Fusion Protein (RFVIIIFC) in Previously Treated Paediatric Subjects with Severe Haemophilia A (Kids A-LONG)
    Young, G.
    Mahlangu, J.
    Kulkarni, R.
    Nolan, B.
    Liesner, R.
    Pasi, J.
    Barnes, C.
    Neelakantan, S.
    Gambino, G.
    Cristiano, L. M.
    Pierce, G. F.
    Allen, G.
    HAEMOPHILIA, 2015, 21 : 32 - 32
  • [39] Low annualized bleeding rates (ABRS) with recombinant factor VIII FC fusion protein (RFVIIIFC) across demographic subgroups of previously treated pediatric subjects with severe hemophilia A
    Young, G.
    Kulkarni, R.
    Ragni, M.
    Brown, S.
    Woznica-Karczmarz, I
    Puetz, J.
    Tamminga, R.
    Gambino, G.
    Pierce, G. F.
    Allen, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 844 - 844
  • [40] Development of a Pegylated Dimeric Recombinant Factor VIII-Fc Fusion Protein for the Treatment for Hemophilia a Patients
    Liu, Bin
    Wang, Xiaoshan
    Li, Xueqin
    Yan, Haixia
    Wang, Shuya
    Zhu, Xi
    Wang, Pengju
    Gao, Jie
    Wang, Yali
    Su, Hongsheng
    BLOOD, 2018, 132
12345